5 Marijuana Stocks To Watch During Canada’s Boom

With Canada primed to have a marijuana stock market boom in 2018, thanks to the country preparing for full legalization across the country in July 2018, it’s time to look at some marijuana stocks that need your attention as 2017 closes out and 2018 approaches.

BayStreet.ca has composed the following list of 5 marijuana stocks of note.

#1 Canopy Growth Corp. (TSX:WEED)

“With a market cap of $3.79 billion, Canopy Growth Corp. is a giant in this space and has seen significant gains in the past year – with its stock price more than doubling since September.”

#2 Cannabis Wheaton (TSX-V:CBWOTC: CBWTF)

“For investors interested in gaining exposure to the entire North American market, Cannabis Wheaton is a company unlike any other.

This innovative company is doing what Silver Wheaton has done for the mining industry and what Netflix has done for movies – Cannabis Wheaton is streaming pot.”

#3 Sanofi (NYSE:SNY)

“The medical marijuana industry is booming, and the one sector that you can be sure will cash in on this craze is big pharma. But for investors this will all be a question of timing. Currently, the giants of the pharma space are biding their time, waiting for the ambitious small caps to get through the cash intensive development and trial stages before swooping in to buy them up.

2018 is going to be the year that big pharma makes its move, as recreational marijuana sends the medical space into overdrive and the late stage developments become ripe for a buyout. These giants won’t be competing with medical marijuana companies, they will own them. So investors can afford to avoid the risk of backing medical marijuana companies and instead just wait on big pharma to reap all of the rewards.”

#4 Pfizer (NYSE:PFE)

“Pfizer is another big pharma pick and boasts some sizzling dividends for investors as well as a very solid growth picture over the past five years. Its two segments, innovative health and essential health, generated $52.8 billion in revenue last year, with net income of $7.2 billion.

While its legacy products may be experiencing declining sales, its new products are very promising, driving its impressive growth in 2017. It is in this new product segment that we will be seeing cannabis breakthroughs and with a market cap of over $215 billion, Pfizer has the influence to bring in winning deals.

Adding to the upside for investors, Pfizer is currently developing two new cancer drugs and an autoimmune disease drug that could be game changing for the sector, and this giants stock price.”

#5 Scotts Miracle-Gro (NYSE:SMG)

“Scotts Miracle-Gro is a ‘pick and shovel’ company for the marijuana industry and is yet another way investors can look to play the boom. As the race for supply heats up, this industry leader will be at the center of it all, providing investors with a fantastic opportunity.

SMG is currently trading at $102.56 having experienced impressive growth for the last five years. With a market cap of nearly $6 billion, it is a name to be reckoned with in one of the hottest markets in the world right now.”

You can read the entire article on their website, which includes full text of each stock’s analysis.